I-125 Brachytherapy for Choroidal Melanoma. Photographic and Angiographic Abnormalities: The Collaborative Ocular Melanoma Study: COMS Report No. 30

Ophthalmology

Volumn 116, Issue 1, 2009, Pages

  Boldt, H Culver ^a   Melia, B Michele ^b   Liu, Judy C ^a   Reynolds, Sandra M ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CHOROID MELANOMA; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; EYE PHOTOGRAPHY; EYE TUMOR; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MICROANEURYSM; OPTIC NERVE DISEASE; PREVALENCE; PRIORITY JOURNAL; RADIATION DOSE; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA MACULOPATHY; RETINA NEOVASCULARIZATION; RETINOPATHY; TELANGIECTASIA;

EID: 57949088569     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.10.013     Document Type: Article

References (45)

1. Bosworth J.L., Packer S., Rotman M., et al. Choroidal melanoma: I-125 plaque therapy. Radiology 169 (1988) 249-251
2. Brady L.W., and Hernandez J.C. Brachytherapy of choroidal melanomas. Strahlenter Onkol 168 (1992) 61-65
3. Jones R., Gore E., Mieler W., et al. Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects. Int J Radiat Oncol Biol Phys 52 (2002) 989-995
4. Moore R.F. Choroidal sarcoma treated by the intraocular insertion of radon seeds. Br J Ophthalmol 14 (1930) 145-152
5. Stallard H.B. Radiant energy as (a) a pathogenic and (b) a therapeutic agent in ophthalmic disorders: Gifford Edmonds prize essay for 1932. Br J Ophthalmol Monograph Suppl 6 (1933) 1-126
6. Stallard H.B. Radiotherapy for malignant melanoma of the choroids. Br J Ophthalmol 50 (1966) 147-155
7. Fontanesi J., Meyer D., Xu S., and Tai D. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys 26 (1993) 619-623
8. Hayreh S.S. Post-radiation retinopathy: a fluorescence fundus angiographic study. Br J Ophthalmol 54 (1970) 705-714
9. Brown G.C., Shields J.A., Sanborn G., et al. Radiation retinopathy. Ophthalmology 89 (1982) 1494-1501
10. Sealy R., le Roux L.M., Rapley F., et al. The treatment of ophthalmic tumours with low-energy sources. Br J Radiol 49 (1976) 551-554
11. Packer S., and Rotman M. Radiotherapy of choroidal melanoma with iodine-125. Ophthalmology 87 (1980) 582-590
12. Packer S., Fairchild R.G., and Salanitro P. New techniques for iodine-125 radiotherapy of intraocular tumors. Ann Ophthalmol 19 (1987) 26-30
13. Packer S., Stoller S., Lesser M.L., et al. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 99 (1992) 767-773
14. Lean E.K., Cohen D.M., Liggett P.E., et al. Episcleral radioactive plaque therapy: initial clinical experience with 56 patients. Am J Clin Oncol 13 (1990) 185-190
15. Hill J.C., Sealy R., Shackleton D., et al. Improved iodine-125 plaque design in the treatment of choroidal malignant melanoma. Br J Ophthalmol 76 (1992) 91-94
16. Mameghan H., Karolis C., Fisher R., et al. Iodine-125 irradiation of choroidal melanoma: clinical experience from the Prince of Wales and Sydney Eye Hospitals. Australas Radiol 36 (1992) 249-252
17. Char D.H., Quivey J.M., Castro J.R., et al. Helium ions versus iodine 125 brachytherapy in the management of uveal melanomas: a prospective, randomized, dynamically balanced trial. Ophthalmology 100 (1993) 1547-1554
18. Kreissig I., Rose D., and Jost B. Long-term follow-up of iodine-125 brachytherapy for choroidal melanomas. Part 1: anatomical results and life expectancy. Eur J Ophthalmol 3 (1993) 121-126
19. Quivey J.M., Char D.H., Phillips T.L., et al. High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 26 (1993) 613-618
20. Quivey J.M., Augsburger J., Snelling L., and Brady L.W. 125I plaque therapy for uveal melanoma: analysis of the impact of time and dose factors on local control. Cancer 77 (1996) 2356-2362
21. De Potter P., Shields C.L., Shields J.A., et al. Plaque radiotherapy for juxtapapillary choroidal melanoma: visual acuity and survival outcome. Arch Ophthalmol 114 (1996) 1357-1365
22. Gragoudas E.S., Li W., Lane A.M., et al. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology 106 (1999) 1571-1577
23. Gündüz K., Shields C.L., Shields J.A., et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 117 (1999) 609-614
24. Gündüz K., Shields C.L., Shields J.A., et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 127 (1999) 579-589
25. Finger P.T., Berson A., Ng T., and Szechter A. Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study. Int J Radiat Oncol Biol Phys 54 (2002) 1438-1445
26. Lommatzsch P.K., Alberti W., Lommatzsch R., and Rohrwacher F. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques. Graefes Arch Clin Exp Ophthalmol 232 (1994) 482-487
27. Jensen A.W., Petersen I.A., Kline R.W., et al. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma. Int J Radiat Oncol Biol Phys 63 (2005) 101-108
28. Earle J., Kline R.K., and Robertson D.M. Selection of iodine 125 for the Collaborative Ocular Melamona Study. Arch Ophthalmol 105 (1987) 763-764
29. Garretson B.R., Robertson D.M., and Earle J.D. Choroidal melanoma treatment with iodine 125 brachytherapy. Arch Ophthalmol 105 (1987) 1394-1397
30. Char D.H., Castro J.R., Quivey J.M., et al. Uveal melanoma radiation: 125I brachytherapy versus helium ion irradiation. Ophthalmology 96 (1989) 1708-1715
31. Wilson M.W., and Hungerford J.L. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 106 (1999) 1579-1587
32. Archer D.B., Amoaku W.M., and Gardiner T.A. Radiation retinopathy: clinical, histopathological, ultrastructural and experimental correlations. Eye 5 (1991) 239-251
33. Guyer D.R., Mukai S., Egan K.M., et al. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology 99 (1992) 1278-1285
34. Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS report number 3. Control Clin Trials 14 (1993) 362-391
35. Nath R., Anderson L.L., Luxton G., et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys 22 (1995) 209-234
36. Ray S.K., Bhatnagar R., Hartsell W.F., and Desai G.R. Review of eye plaque dosimetry based on AAPM Task Group 43 recommendations. Int J Radiat Oncol Biol Phys 41 (1998) 701-706
37. Jonckheere A.R. A distribution-free K-sample test against ordered alternatives. Biometrika 41 (1954) 133-145
38. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060
39. Collaborative Ocular Melanoma Study Group. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study. COMS report no. 27. Ophthalmology 114 (2007) 1363-1371
40. Irvine A.R., and Wood I.S. Radiation retinopathy as an experimental model for ischemic proliferative retinopathy and rubeosis iridis. Am J Ophthalmol 103 (1987) 790-797
41. Amoaku W.M., and Archer D.B. Cephalic radiation and retinal vasculopathy. Eye 4 (1990) 195-203
42. Viebahn M., Barricks M.E., and Osterloh M.D. Synergism between diabetic and radiation retinopathy: case report and review. Br J Ophthalmol 75 (1991) 629-632
43. Kinyoun J.L., Lawrence B.S., and Barlow W.E. Proliferative radiation retinopathy. Arch Ophthalmol 114 (1996) 1097-1100
44. Collaborative Ocular Melanoma Study (COMS) Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28. Arch Ophthalmol 124 (2006) 1684-1693
45. Amoaku W.M., Lafaut B., Sallet G., and De Laey J.J. Radiation choroidal vasculopathy: an indocyanine green angiography study. Eye 9 (1995) 738-744